BlackRock, Inc. (BLK) 13D/13G Filings for Larimar Therapeutics, Inc. (LRMR)

BlackRock, Inc. 13D and 13G filings for Larimar Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-04-22
2:28 pm
Sale		 2025-03-31 13G Larimar Therapeutics, Inc.
LRMR		 BlackRock Inc.
BLK		 3,079,665
4.800%		 -186,240decrease
(-5.70%)		 Filing
2025-02-04
3:45 pm
Purchase		 2024-12-31 13G Larimar Therapeutics, Inc.
LRMR		 BlackRock Inc.
BLK		 3,265,905
5.100%		 3,265,905increase
(New Position)		 Filing